US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Ethanol 70% 0.5ml Syringe

Reason Lack of sterility assurance

Sentara Infusion Services D-0292-2023
Class II · Moderate risk Terminated

Ertapenem

Reason Lack of sterility assurance

Sentara Infusion Services D-0291-2023
Class II · Moderate risk Terminated

Dobutamine

Reason Lack of sterility assurance

Sentara Infusion Services D-0290-2023
Class II · Moderate risk Terminated

Dextrose 10% 720ML

Reason Lack of sterility assurance

Sentara Infusion Services D-0288-2023
Class II · Moderate risk Terminated

Daptomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0287-2023
Class II · Moderate risk Terminated

Daptomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0286-2023
Class II · Moderate risk Terminated

D5 Ns 2300ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0284-2023
Class II · Moderate risk Terminated

Ceftriaxone

Reason Lack of sterility assurance

Sentara Infusion Services D-0283-2023
Class II · Moderate risk Terminated

Ceftriaxone

Reason Lack of sterility assurance

Sentara Infusion Services D-0282-2023
Class II · Moderate risk Terminated

Cefoxitin

Reason Lack of sterility assurance

Sentara Infusion Services D-0281-2023
Class II · Moderate risk Terminated

Cefepime

Reason Lack of sterility assurance

Sentara Infusion Services D-0280-2023
Class II · Moderate risk Terminated

Cefazolin

Reason Lack of sterility assurance

Sentara Infusion Services D-0278-2023
Class II · Moderate risk Terminated

Caspofungin 50mg in Ns 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0277-2023
Class II · Moderate risk Terminated

Ampicillin 8gm in Ns 400ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0275-2023
Class II · Moderate risk Terminated

Ampicillin 12gm in Ns 600m

Reason Lack of sterility assurance

Sentara Infusion Services D-0274-2023
Class II · Moderate risk Terminated

Amikacin 450MG IN NS 45ML

Reason Lack of sterility assurance

Sentara Infusion Services D-0273-2023
Class II · Moderate risk Terminated

0.9% Sodium Chloride

Reason Lack of sterility assurance

Sentara Infusion Services D-0272-2023
Class II · Moderate risk Terminated

Voriconazole 10mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0243-2023
Class II · Moderate risk Terminated

Vitamin D3-Aqueous- 10

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0242-2023
Class II · Moderate risk Terminated

Vancomycin Fortified 10mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0241-2023
Class II · Moderate risk Terminated

Tobramycin Fortified 15mg/Ml Oph Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0240-2023